Irreversible Pulpitis Completed Phase 2 Trials for Lidocaine (DB00281)

IndicationStatusPhase
DBCOND0047915 (Irreversible Pulpitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01572116Effect of Sufentanil on the Rate of AnesthesiaPrevention